Helixgate

Helixgate

Uncategorized

Activist investor revives campaign to overhaul Novavax board

Shah Capital, which has agitated for change at the vaccine maker for years, is calling on fellow shareholders to end what it calls “dogmatic leadership” that’s led to the “destruction” of Novavax’s equity value. 

Read More

Published

on

Shah Capital, which has agitated for change at the vaccine maker for years, is calling on fellow shareholders to end what it calls “dogmatic leadership” that’s led to the “destruction” of Novavax’s equity value. 

Read More

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

Trump, FDA plan to expedite psychedelic development

Published

on

Over the weekend, President Donald Trump endorsed the potential of psychedelic treatments and vowed to expedite their research and development as remedies for severe mental health conditions, a seminal moment for a field long shunned …

Continue Reading

Uncategorized

RFK Jr. defends HHS tenure, 12% proposed budget cut

Republicans largely praised the HHS secretary’s track record during a marathon of House hearings last week, but some raised concerns about proposed budget cuts to the National Institutes of Health.

Read More

Published

on

Republicans largely praised the HHS secretary’s track record during a marathon of House hearings last week, but some raised concerns about proposed budget cuts to the National Institutes of Health.

Read More

Continue Reading

Uncategorized

Novartis cuts two programs in cancer-related blood clots

Published

on

Novartis has axed two late-stage programs in cancer-related blood clots after observing “inferior efficacy” in a clinical trial.

The move marks a setback for a candidate that Novartis out-licensed in 2019, then

Continue Reading
Advertisement

Trending